News24 | The Global Fund will roll out the twice-yearly anti-HIV jab – with or without Pepfar

The Global Fund to Fight AIDS, Tuberculosis and Malaria says it will fund the rollout of the twice-yearly anti-HIV jab, lenacapavir, for poorer countries, including South Africa, with or without the help of the US government’s AIDS fund, Pepfar.